Nov 9 (Reuters) - Medibio Ltd MEB.AX :
* PROVIDES UPDATE ON FDA PROCESS
* FDA REQUESTS CLARIFICATION ON 11 KEY POINTS OF THE DE NOVO APPLICATION
* WHIL DE NOVO APPLICATION WILL TAKE LONGER THAN ORIGINALLY ANTICIPATED, FULL MEDIBIO TEAM WILL IMMEDIATELY PURSUE 510K APPLICATION